HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $20 Price Target

HC Wainwright & Co. analyst Arthur He has reiterated a Buy rating on Solid Biosciences (NASDAQ: SLDB) and maintained a price target of $20 for the company's stock.